Skip to content

Comparative Evaluation of Corneal Staining With Balafilcon A Lenses and Two Multi-Purpose Solutions

Status
Completed
Phases
Phase 1Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01024855
Enrollment
30
Registered
2009-12-03
Start date
2009-04-30
Completion date
2009-06-30
Last updated
2015-10-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Astigmatism, Hyperopia, Myopia

Brief summary

A new multi-purpose solution (MPS)was clinically evaluated against Opti-Free RepleniSH MPS at specific time points over the course of four days. The study was conducted with PureVision lenses.

Interventions

DEVICERevitaLens OcuTec MPS (Investigational MPS) and Opti-Free RepleniSH MPS (control)

multi-purpose lens care solution

Sponsors

Abbott Medical Optics
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 99 Years
Healthy volunteers
Yes

Inclusion criteria

* were at least 18 years old; * were experienced contact lens wearers; * were correctable to at least 20/40 or better in both eyes with contact lenses; * were in good general health, with healthy eyes (other than requiring vision correction); * had not worn lenses for at least 12 hours before each baseline visit; * had a corneal staining score no greater than Grade 1 in either eye at time of enrollment; * had previously used an MPS or hydrogen peroxide solution successfully.

Exclusion criteria

* had a confirmed diagnosis of Sjögren's syndrome or other condition that results in a chronic and/or pathologic dry eye condition; * required concurrent ocular medication or have used ocular medication within 24 hours of entering the study; * had a known sensitivity or intolerance to any MPS, study products or ingredient(s); * were currently participating in any other clinical study; * had a condition or are in a situation that, in the investigator's opinion, may put them at significant risk, confound the study results, or interfere significantly with their participation in the study.

Design outcomes

Primary

MeasureTime frameDescription
Number of Eyes With No Change in Corneal StainingChange from baseline after 1, 2, 4 and 6+ hours of wearSubjects examined after corneal staining (a method used to assess the condition of the cornea) using a slit lamp to determine change from baseline and rated based on the following scale: 0=no change from baseline, 1=trace, 2=mild, 3=moderate, 4=severe.

Countries

United States

Participant flow

Recruitment details

Recruitment of employees occurred 7/8/2010 - 10/1/2010 thru employee bulletin for study taking place at in-house optometric clinic.

Pre-assignment details

Prior to baseline visit subjects were instructed to undergo a washout period where no contacts were worn for 12 hours. Slit lamp exam was conducted prior to randomized group assignment. Eyes were thoroughly rinsed with unit-dose aline before pre-soaked study lenses were inserted.

Participants by arm

ArmCount
RevitaLens and OptiFree
30 subjects, one eye received RevitaLens MPS (investigational), one eye received Opti-Free RepleniSH MPS(control).
30
Total30

Withdrawals & dropouts

PeriodReasonFG000
Overall StudyInclusion/exclusion criteria1

Baseline characteristics

CharacteristicRevitaLens and OptiFree
Age, Categorical
<=18 years
0 Participants
Age, Categorical
>=65 years
0 Participants
Age, Categorical
Between 18 and 65 years
30 Participants
Region of Enrollment
United States
30 participants
Sex/Gender, Customized
Unknown
30 participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
— / —
other
Total, other adverse events
0 / 30
serious
Total, serious adverse events
0 / 30

Outcome results

Primary

Number of Eyes With No Change in Corneal Staining

Subjects examined after corneal staining (a method used to assess the condition of the cornea) using a slit lamp to determine change from baseline and rated based on the following scale: 0=no change from baseline, 1=trace, 2=mild, 3=moderate, 4=severe.

Time frame: Change from baseline after 1, 2, 4 and 6+ hours of wear

Population: per protocol

ArmMeasureGroupValue (NUMBER)
RevitaLensNumber of Eyes With No Change in Corneal Staining4 Hours - No Change21 eyes
RevitaLensNumber of Eyes With No Change in Corneal Staining2 Hours - No Change19 eyes
RevitaLensNumber of Eyes With No Change in Corneal StainingEnd of Day (>6 hrs) - No Change19 eyes
RevitaLensNumber of Eyes With No Change in Corneal Staining1 Hour - No Change16 eyes
OptiFreeNumber of Eyes With No Change in Corneal Staining2 Hours - No Change14 eyes
OptiFreeNumber of Eyes With No Change in Corneal Staining1 Hour - No Change17 eyes
OptiFreeNumber of Eyes With No Change in Corneal StainingEnd of Day (>6 hrs) - No Change20 eyes
OptiFreeNumber of Eyes With No Change in Corneal Staining4 Hours - No Change21 eyes

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026